October 21, 2019 ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference
August 19, 2019 Inclusion of the first patient in Abivax's Phase 2b (ABX464-103) clinical trial for the treatment of hemorrhagic rectocolitis
February 4, 2025 Artedrone announces the appointment of Liane Teplitsky as CEO, Dan Raffi and Nnamdi Njoku to its Board of Directors
January 30, 2025 Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
